Full event guide
Here's a sneak peek of the takeaways from attending this meeting:
- Explore the role of immunotherapy for the treatment of prostate cancer
- Discover how to Bring theranostics to prostate cancer
- Evaluate how to Optimize strategies for overcoming the immunosuppressive prostate tumor microenvironment
- Assess the opportunities and challenges for T-cell directed therapies in prostate cancer
- Examine next-generation small molecule inhibitors, degraders of androgen receptor (AR) and AR-splice variants
Sounds interesting? Download our official agenda to see the session details and our speaker faculty with the likes of Amgen, Bristol-Myers Squibb, Novartis and Noxopharm.